Estimated Prevalence and Testing for Albuminuria in US Adults at Risk for Chronic Kidney Disease

Figure 1.. Estimated Albuminuria Prevalence and Proportion Detected Among Patients With Hypertension and/or Diabetes (N = 192 108) Detected albuminuria prevalence refers to tested patients having albuminuria ≥30 mg/g. Undetected albuminuria prevalence is the estimated prevalence of albuminuria ≥30 mg/g based on patient characteristics among the untested population. D indicates diabetes; eGFR, estimated glomerular filtration rate (measured in mL/min/1.73 m2); HTN, hypertension. aOther race and ethnicity includes American Indian or Alaska Native, Asian, Native Hawaiian or Other Pacific Islander.

Figure 2.. Therapy Among Tested and Untested Patients by Quintile of Estimated Risk of Albuminuria (N = 149 554) ACEi indicates angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; SGLT2i, sodium-glucose cotransporter 2 inhibitor. aQuintile with a statistically significant difference between tested and untested groups. All comparisons of tested vs untested were significant to P < .001 except for the following: blood pressure less than 130/80 mm Hg for quintile 2 (P = .01), blood pressure less than 130/80 mm Hg for quintile 5 (P = .75), blood pressure less than 140/90 mm Hg for quintile 1 (P = .44), and blood pressure less than 140/90 mm Hg for quintile 2 (P = .02).